Aquestive Therapeutics (AQST)
Nasdaq • AQST • US03843E1047
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 24.7% of free float sold short, 12.9 days to cover, cost to borrow 1.35%. Sign up for live short interest data.
Market Cap
445m USD | # 6175 in US
Volume
2.77m shares | 12.47m USD
Shares Outstanding
125.69m
Free Float Shares
90.07% | 113.2m
